ANDA 74357, held by Teva. Trazodone Hydrochloride.
As of Nov 16, 2026, ANDA 74357 (Trazodone Hydrochloride), held by Teva, was first approved by FDA on Apr 30, 1997, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 30, 1997 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Trazodone Hydrochloride150MG · tablet;oral | Trazodone Hydrochloride | Discontinued |
| Nov 17, 2014 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jun 26, 2007 | Supplement 5Labeling | Approved | None posted |
| Jan 4, 2001 | Supplement 4Labeling | Approved | None posted |
| Dec 2, 1999 | Supplement 1Manufacturing | Approved | None posted |
| Dec 2, 1999 | Supplement 2Manufacturing | Approved | None posted |
| Dec 2, 1999 | Supplement 3Labeling | Approved | None posted |
| Apr 30, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters